Group One Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History

Group One Trading’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,100	Closed	-$11K	–	9193
2021 Q4	$11K	Sell	9,100 -33,400	-79%	-$49.8K	﹤0.01%	7332
2021 Q3	$82K	Buy	+42,500	New	+$83.6K	﹤0.01%	6110
2021 Q1	–	Sell	-4,500	Closed	-$11K	–	8319
2020 Q4	$11K	Sell	4,500 -2,500	-36%	-$5.7K	﹤0.01%	5770
2020 Q3	$16K	Buy	7,000 +5,500	+367%	+$14.4K	﹤0.01%	5248
2020 Q2	$3K	Buy	+1,500	New	+$3.45K	﹤0.01%	5532
2019 Q3	–	Sell	-700	Closed	-$3K	–	5884
2019 Q2	$3K	Buy	+700	New	+$3.65K	﹤0.01%	4736

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Group One Trading's GNCA Position: Q2 2022 in Review

Group One Trading sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 50,517 shares — an estimated $63K sold.

Group One Trading first reported a position in GNCA in Q2 2018 and held it in 11 quarters. The position peaked at $118K in Q3 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Group One Trading reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Group One Trading sold 50,517 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $63K.
Group One Trading first reported a position in Genocea Biosciences, Inc. in Q2 2018 and held it in 11 quarters.
Group One Trading's Genocea Biosciences, Inc. position peaked at $118K in Q3 2021.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.